Access-H20: Sensor-driven smart faucet to enable and empower independent drinking and grooming for individuals impacted by spinal cord injury

项目摘要/摘要 I-Corps™计划的目标是通过以下方式加快生物医学研究向市场的转化 在创新和创业领域向SBIR和STTR受赠者提供培训。在这项计划下， NIH将促进Nasoni的发展，重点是教Nasoni研究人员如何获得更清晰的 了解其发明在市场上的价值，以及最终如何从 将研究实验室带入商业世界。该计划旨在补充 母公司SBIR第一阶段(R43)赠款，帮助加快Nasoni从NIH获得的Access H2OTM的商业化 资助技术可行性研究。 通过这一计划，纳索尼的i-Corps™团队将参加一个创业沉浸式课程。I-Corps™ 课程使用假设驱动的客户发现方法来洞察以下相关问题 技术商业化。作为这项计划的一部分，纳索尼的团队成员被要求走出实验室，并 通过对潜在客户、战略合作伙伴和其他客户进行多次(即100+)访谈来收集信息 第三方利益相关者。 在课程期间，纳索尼的i-Corps™团队将与i-Corps教练和其他团队分享他们所学到的东西，获得 对SBIR赠款下正在开发的技术的预期影响的新见解。预计 在I-Corps™计划期间获得的反馈和学习将有助于为Nasoni的第二阶段SBIR项目和 商业化战略。 。

PROJECT SUMMARY/ABSTRACT The goal of the I-Corps™ Program is to accelerate the translation of biomedical research to the marketplace by providing training to SBIR and STTR grantees in the areas of innovation and entrepreneurship. Under this program, the NIH will foster the development of Nasoni, with a focus on teaching Nasoni researchers how to gain a clearer understanding of the value of its inventions in the marketplace, and ultimately how to advance their technologies from the research lab into the commercial world. This program is designed to complement activities within the scope of the parent SBIR Phase I (R43) grant, to help accelerate the commercialization of Nasoni's Access H2OTM derived from NIH funded technical feasibility studies. Through this program, Nasoni's I-Corps™ team will participate in an entrepreneurial immersion course. The I-Corps™ curriculum uses a hypothesis-driven method of customer discovery to gain insights into the issues associated with technology commercialization. As part of this program, Nasoni's team members are required to get "out of the lab" and gather information by conducting many interviews (i.e., 100+) with potential customers, strategic partners, and other third-party stakeholders. During the course, Nasoni's I-Corps™ team will share what they learn with I-Corps instructors and other teams, gaining new insights into the prospective impact of the technology being developed under the SBIR grant. It is anticipated that the feedback and learning gained during the I-Corps™ program will help inform Nasoni's Phase II SBIR project and commercialization strategies. .